Monitor for any subsequent prospectus supplement or takedown announcement indicating the company intends to draw on the shelf. While no immediate offering is priced, the effective shelf combined with insider selling suggests capital pressure. A future offering would likely be dilutive given the small market cap.
Price Chart
Executive Summary
Cadrenal Therapeutics' S-3 shelf registration statement (File No. 333-297432) became effective on July 20, 2026, allowing the company to offer and sell securities from time to time. For a micro-cap company with a $6M market cap and recent insider selling, the effective shelf creates an overhang of potential dilution, though no immediate offering has been announced.
Key Facts
- S-3 shelf registration declared effective on July 20, 2026.
- SEC file number: 333-297432, under the 1933 Act.
- Company is a pharmaceutical development stage firm with $6M market cap.
- Insiders sold $96K in the preceding 30 days (5 transactions).
Financial Impact
No dollar amount for the shelf offering is disclosed; the effective registration permits future capital raises with dilutive potential.
Risk Factors
- Potential near-term equity issuance diluting existing shareholders.
- Limited cash runway likely necessitating capital raise; shelf enables rapid access.
- Historical insider selling and poor model track record indicate caution.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002367 |
| Document: 9999999995-26-002367-index.html | 9999999995-26-002367 |
| Document: 9999999995-26-002367.txt | 9999999995-26-002367 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 8-K | $0.9723 | awaiting T+60 | — | $0.9100 (−6.41%) |
Aug 31, 2026 8w ago | 8-K | $1.75 | awaiting T+60 | — | $0.9100 (−48.00%) |
Jul 21, 2026 14w ago | 8-K | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9100 (−58.06%) |
Jul 21, 2026 14w ago | EFFECT | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9100 (−58.06%) |
Jul 1, 2026 16w ago | Press Release | $3.60 $1.12 | ▲ +68.89% | ▲ +71.94% | $0.9100 (+74.72%) |
Jun 29, 2026 17w ago | 8-K | $3.34 $1.32 | ▼ −60.48% | ▼ −64.04% | $0.9100 (−72.75%) |
Jun 18, 2026 18w ago | 8-K | $3.50 $1.06 | ▼ −69.71% | ▼ −71.61% | $0.9100 (−74.00%) |
Jun 15, 2026 19w ago | 144 | $3.04 $1.18 | ▲ +61.18% | ▲ +62.18% | $0.9100 (+70.07%) |
May 7, 2026 24w ago | Press Release | $6.02 $1.96 | ▼ −67.44% | ▼ −71.27% | $0.9100 (−84.88%) |
Apr 30, 2026 25w ago | 8-K | $6.67 $2.06 | ▼ −69.12% | ▼ −72.22% | $0.9100 (−86.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers